Volume | 1,112,845 |
|
|||||
News | - | ||||||
Day High | 0.8356 | Low High |
|||||
Day Low | 0.7583 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Gritstone bio Inc | GRTS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.7583 | 0.7583 | 0.8356 | 0.8134 | 0.7645 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,963 | 1,112,845 | $ 0.7973486 | $ 887,325 | - | 0.6716 - 3.33 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:50:23 | formt | 422 | $ 0.82 | USD |
Gritstone bio (GRTS) Options Flow Summary
Gritstone bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
80.41M | 98.07M | - | 16.34M | -138.49M | -1.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Gritstone bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GRTS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.746 | 0.8356 | 0.685 | 0.7568981 | 2,054,448 | 0.074 | 9.92% |
1 Month | 2.67 | 2.67 | 0.6716 | 1.09 | 5,275,481 | -1.85 | -69.29% |
3 Months | 2.44 | 3.10 | 0.6716 | 1.59 | 2,825,332 | -1.62 | -66.39% |
6 Months | 1.89 | 3.17 | 0.6716 | 1.84 | 2,321,410 | -1.07 | -56.61% |
1 Year | 2.47 | 3.33 | 0.6716 | 1.94 | 1,898,677 | -1.65 | -66.80% |
3 Years | 9.46 | 14.42 | 0.6716 | 4.05 | 1,350,340 | -8.64 | -91.33% |
5 Years | 10.76 | 34.67 | 0.6716 | 6.77 | 1,081,442 | -9.94 | -92.38% |
Gritstone bio Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others. |